Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 24339874 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | brain disorders | NA | NA | NA | unclassified | |
| the chemokine interferon gamma-induced protein 10 (ip-10) and human leukocyte antigen (hla) are widely used indicators of glial activation and neuroinflammation and are up-regulated in many brain disorders. | |||||||
| 24349220 | HLA-B (HLA-B) | pleurisy | NA | NA | NA | unclassified | |
| human cd8+ t cells from tb pleurisy respond to four immunodominant epitopes in mtb cfp10 restricted by hla-b alleles. | |||||||
| 30060244 | HLA-B*27 | neck pain | NA | NA | NA | unclassified | |
| back or neck pain was present in 97% of the patients (mean age 61.2 years, 90% male) and hla-b27 was positive in 9/27 documented measurements. | |||||||
| 24413066 | HLA (HLA) | t-lgl leukemia | NA | NA | NA | unclassified | |
| in the present study, we explored the association between expanded tcr-vb and tcr-va clonotypes in a cohort of 26 cd8(+)/tcrab(+) t-lgl leukemia patients, in conjunction with the hla-abc genotype, to find indications for common antigenic stimuli. | |||||||
| 24428874 | HLA-B*51 | hyperhomocysteinemia | Iranian | NA | NA | positive+negation | |
| there was no significant difference between hla-b51 positive and negative individuals either in the mean plasma homocysteine levels (13.59 +- 9.03 vs. 12.95 +- 4.98 mmol/l, p = 0.514), or in the prevalence of hyperhomocysteinemia (17% vs. 21.4%, p = 0.504). | |||||||
| 24428874 | HLA-B*51 | hyperhomocysteinemia | Iranian | NA | NA | unclassified | |
| in hla-b51 positive and negative bd patients, mean plasma homocysteine levels were 14.29 +- 12.02 and 12.62 +- 4.79 mmol/l, respectively (p = 0.33), and the prevalence of hyperhomocysteinemia was 20.8% versus 19.5% (p = 0.55). | |||||||
| 24428874 | HLA-B*51 | hyperhomocysteinemia | Iranian | NA | NA | unclassified | |
| in the control group, the mean plasma homocysteine levels in hla-b51 positive and negative individuals were 12.85 +- 4.28 and 13.14 +- 5.10 mmol/l, respectively (p = 0.794), and the prevalence of hyperhomocysteinemia was 13% versus 22.1% (p = 0.23). | |||||||
| 24433325 | HLA (HLA) | specific language impairment | NA | NA | NA | unclassified | |
| associations of hla alleles with specific language impairment. | |||||||
| 24433325 | HLA (HLA) | specific language impairment | NA | NA | NA | negation | |
| however, to date, no studies have investigated the possible involvement of hla loci in specific language impairment (sli), a disorder that is defined primarily upon unexpected language impairment. | |||||||
| 24433325 | HLA (HLA) | language disorders | NA | NA | NA | unclassified | |
| these preliminary data provide an intriguing link to those described by previous studies of other neurodevelopmental disorders and suggest a possible role for hla loci in language disorders. | |||||||
Copyright 2024